 ROCKVILLE, Md., March 10, 2022 GLOBE NEWSWIRE -- Synthetic Biologics, Inc. NYSE American: SYN, a diversified clinical-stage company developing therapeutics designed to treat diseases in areas of high unmet need, today announced that it plans to host a conference call on Wednesday, March 16, 2022, at 4:30 p.m. ET to discuss its financial results for the year ended December 31, 2021 and provide a corporate update. 